Last reviewed · How we verify
Progesterone Soft Capsules
Progesterone is a naturally occurring steroid hormone that plays a crucial role in the menstrual cycle and in maintaining the early stages of pregnancy.
Progesterone is a naturally occurring steroid hormone that plays a crucial role in the menstrual cycle and in maintaining the early stages of pregnancy. Used for Treatment of secondary amenorrhea and abnormal uterine bleeding due to hormonal imbalance, Maintenance of early pregnancy.
At a glance
| Generic name | Progesterone Soft Capsules |
|---|---|
| Sponsor | Changchun GeneScience Pharmaceutical Co., Ltd. |
| Drug class | Progestogen |
| Target | Progesterone receptor |
| Modality | Small molecule |
| Therapeutic area | Gynecology |
| Phase | Phase 3 |
Mechanism of action
Progesterone helps to prepare the uterus to implant a fertilized egg and maintains the pregnancy by promoting the growth of the embryo and suppressing the uterine contractions. It also has a role in the development of the placenta and the regulation of the menstrual cycle.
Approved indications
- Treatment of secondary amenorrhea and abnormal uterine bleeding due to hormonal imbalance
- Maintenance of early pregnancy
Common side effects
- Nausea
- Headache
- Dizziness
- Breast tenderness
- Weight gain
Key clinical trials
- Comparison of Two Vaginal Progesterone Forms in Frozen Embryo Transfer
- Multifaceted Benefits of Auricular Point Sticking for IVF Patients: Psychological Well-being, Sleep, and Treatment Outcomes (NA)
- Nintedanib for Improving Reproductive Outcomes in Adenomyosis (PHASE3)
- Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer (PHASE2)
- Progesterone Primed Endometrial Protocol Versus Gonadotropin-releasing Hormone Antagonist Protocol in Assisted Reproductive Treatments (NA)
- Effect of Menopause Hormone Therapy In Postmenopausal Women With CSVD And MCI (PHASE2)
- Fasting Bioequivalence Study of 2 Oral Progesterone Soft Capsules 200 mg in 48 Healthy Female Subjects (PHASE1)
- Fasting Bioequivalence Study of 2 Progesterone Soft Capsules 200 mg in 66 Healthy Female Subjects Under Vaginal Route (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Progesterone Soft Capsules CI brief — competitive landscape report
- Progesterone Soft Capsules updates RSS · CI watch RSS
- Changchun GeneScience Pharmaceutical Co., Ltd. portfolio CI